International Journal of Drug Policy
Volume 21, Issue 2 , Pages 94-96, March 2010

Public Health and the origins of the Mersey Model of Harm Reduction

NHS Cumbria, Ginny Hall, Dent, Cumbria, LA10 5TD, UK

Received 2 November 2009; received in revised form 6 January 2010; accepted 6 January 2010. published online 17 February 2010.

Abstract 

In the mid-1980s in Liverpool, and the area surrounding it (Merseyside and Cheshire), harm reduction was adopted on a large scale for the first time in the UK. The harm reduction model was based on a population approach to achieve the public health goal of reducing the harm to health associated with drug use. The particular concern at that time was the risk of HIV infection, but there was also the issue of the health of a group of young people who were under-served by health services. To achieve the goal, services were developed that would attract the majority of those at risk within the community, not simply the few who wished to stop using drugs, and which would enable contact with the target group to be maintained so as to bring about the necessary changes in behaviour required to maintain health and reduce risk. This Commentary describes some of the background to the development of the Mersey Model of Harm Reduction from the memories and perspectives of two people who promoted harm reduction within the health service and the region.

Keywords: Harm reduction, Syringe exchange, Liverpool, Merseyside

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(10)00005-8

doi:10.1016/j.drugpo.2010.01.004

International Journal of Drug Policy
Volume 21, Issue 2 , Pages 94-96, March 2010